Clinical trial

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

NCT03264352

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2018-02-01

PhasePHASE4

Study timeline

Study start (actual)2018-02-01Date precision: day

Registry last updated2026-09-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Adverse Eventunresolved

Blood Pressureunresolved

Prehypertensionunresolved

Cardiovascular Risk Factorunresolved

Interventions

Allisartan IsoproxilDRUG

Amlodipine 5mgDRUG

Standard treatment by current guidelineOTHER

Sponsors & collaborators

XueQing Yulead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03264352 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.